Seattle is on the rise as one of biopharma’s hottest spaces in cell and gene therapy. The BioForest region of Washington and Oregon continues to grow as more companies move to the region.
Companies such as Sana Biotechnology, Umoja Biopharma, and Sonoma Biotherapeutics are taking note of the elite talent pool, high concentration of tech companies and the potential for startup growth in the region.
“This talent, combined with a mix of large and emerging companies, has given the area the critical mass to be a sustainable life sciences hub,” said Sana CEO Steve Harr. “Seattle’s strong foundation in cell and gene therapy and oncology is what drew Sana to the area.”